Welcome to our dedicated page for GE Aerospace news (Ticker: GE), a resource for investors and traders seeking the latest updates and insights on GE Aerospace stock.
GE Aerospace reports news on its aircraft engine, services, and systems business, including commercial engine orders, long-term service support, maintenance, repair and overhaul investments, and digital tools used in production, supply chain, and military aircraft readiness. Coverage includes customer selections for GEnx and other GE Aerospace or CFM-powered fleets, dividend declarations, workforce-training initiatives, and governance matters involving defense-related products.
GE Healthcare has been awarded the 2020 Global Company of the Year by Frost & Sullivan for its innovative AI-based command centers that enhance hospital efficiency. The solution integrates data from existing hospital systems to improve resource optimization. Command centers can yield a return on investment in 18 to 24 months and increase bed capacity by 15 to 30 beds without physical expansion. Currently, over 210 hospitals across 6 countries utilize GE’s command center software, which leverages advanced technologies such as predictive analytics and machine learning.
GE Digital has been recognized as a leader in Asset Performance Management (APM) across key industries including Oil & Gas, Utilities, Mining, and Manufacturing by IDC's MarketScape 2020-2021. This acknowledgment is attributed to GE Digital's robust APM solutions, which utilize advanced analytics and Digital Twin technology to optimize asset performance. The report highlights the company's user interface, customer-centric approach, and the modularity of its solutions as significant strengths, ensuring effective scaling for various industrial applications.
General Electric (NYSE: GE) announced the results of its Offers to purchase cash for U.S. Dollar, Euro, and GBP Notes. The Offers, which expired on December 17, 2020, included Pool 1 and Pool 2 Notes, with a total consideration nearing $2.17 billion. All validly tendered Pool 1 Notes will be purchased, whereas only Pool 2 Notes with Acceptance Priority Levels 1 to 4 will be accepted due to a cap on total consideration. Holders of accepted Notes will receive payment on December 22, 2020. The Offer was facilitated by several financial institutions and has specific conditions for participation.
GE Healthcare has partnered with Oregon Health & Science University (OHSU) to implement a multi-year Virtual ICU (VICU) initiative across eight hospital sites. This collaboration aims to address the critical shortage of healthcare specialists highlighted during the COVID-19 pandemic. The Mural Virtual Care Solution will enhance local patient care, optimizing ICU capacity and reducing unnecessary transfers. The platform integrates real-time data across systems, aiding in compliance and improving patient outcomes. Mural is available in several countries, designed to increase efficiency and support healthcare teams.
GE Healthcare (NYSE: GE) has partnered with St. Luke’s University Health Network in Pennsylvania to pilot the U.S.'s first rapid diagnostic breast cancer center model, the One-Stop Clinic. This model enhances clinical outcomes by streamlining the diagnosis and treatment planning process, reducing wait times significantly from an average of 26 days to potentially 36 hours. The project is backed by Premier Applied Sciences, aiming to share insights with other health systems. The clinic began piloting operations this year, seeking to improve the patient experience while mitigating COVID-19 exposure risks.
The Board of Directors of GE declared a $0.01 per share dividend on its common stock. This dividend is payable on January 25, 2021 to shareholders of record by the close of business on December 21, 2020. The ex-dividend date is set for December 18, 2020. This decision reflects GE's ongoing commitment to returning value to its shareholders amid its focus on operational efficiency and reliability as it continues to evolve in the industrial sector.
GE (NYSE:GE) announced cash offers to purchase all U.S. Dollar, Euro, and GBP denominated notes originally issued by affiliated companies. The total purchase price for Pool 2 Notes is limited to $1.4 billion, contingent on conditions being met. The offers commence on December 11, 2020, and expire on December 17, 2020. Holders can withdraw tendered notes before the withdrawal deadline. Successful tenders will lead to immediate cash payments based on predefined total considerations for each note series. All accepted notes will be retired and canceled.
GE Healthcare has introduced innovative AI solutions to address the dual challenge of providing high-quality healthcare while managing increased workflow pressures due to COVID-19. The company is expanding its Edison intelligence portfolio and launching advanced imaging technologies to enhance patient outcomes. Major launches include photon-counting CT technology, TrueFidelity imaging, and the AIR Recon DL technology, which promises significant exam time reductions. These developments signal GE’s commitment to precision health and support healthcare providers amidst the pandemic's ongoing challenges.
GE Healthcare has launched a groundbreaking AI algorithm designed for assessing Endotracheal Tube (ETT) placements in critically ill COVID-19 patients. This innovation, part of the Critical Care Suite 2.0, addresses the alarming statistic that up to 25% of patients intubated outside the operating room have misplaced tubes. The AI provides quick, accurate measurements directly from mobile x-ray devices, potentially preventing severe complications. The suite enhances workflow efficiency and is co-developed with UC San Francisco, leveraging GE's Edison platform for rapid deployment.
GE Healthcare has acquired Prismatic Sensors AB, a Swedish company specializing in photon counting detectors, reinforcing its commitment to advancing photon counting CT technology. This acquisition aims to enhance clinical applications in oncology, cardiology, and neurology, potentially setting a new standard of care. Prismatic’s innovative Deep Silicon detectors promise improved tissue characterization, spatial resolution, and reduced radiation doses. The acquisition is expected to close by January 2021, with GE Healthcare poised to leverage its nearly 50 years of experience in CT technology for future advancements.